Trade Summary

2 days ago, Bjerkholt Eric, serving as CFO at Mirum Pharmaceuticals, Inc. (MIRM), sold 7,287 shares at $91.98 per share, for a total transaction value of $670,243.00. Following this transaction, Bjerkholt Eric now holds 49,788 shares of MIRM.

This sale represents a 13.00% decrease in Bjerkholt Eric's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 1 day after the trade was made.

Mirum Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.